Related references
Note: Only part of the references are listed.Unusual mid-shaft fractures during long-term bisphosphonate therapy
Clarita V. Odvina et al.
CLINICAL ENDOCRINOLOGY (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis
Bo Abrahamsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Atypical Femoral Fractures and Bisphosphonate Use
Christian M. Girgis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate
Jorg Schilcher et al.
ACTA ORTHOPAEDICA (2009)
Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates A Case Series from a Swiss University Hospital
Kuntheavy Ing-Lorenzini et al.
DRUG SAFETY (2009)
Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study
Bo Abrahamsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
B. A. Lenart et al.
OSTEOPOROSIS INTERNATIONAL (2009)
An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
Ernest Beng Kee Kwek et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2008)
Severely suppressed bone turnover and atypical skeletal fragility
Maja Visekruna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low-energy femoral shaft fractures associated with alendronate use
Andrew S. Neviaser et al.
JOURNAL OF ORTHOPAEDIC TRAUMA (2008)
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
Brett A. Lenart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Severely suppressed bone turnover: A potential complication of alendronate therapy
CV Odvina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)